Johnson & Johnson Tops Q3 Earnings Forecast, Boosts 2022 Outlook On Pharma Strength
Our third quarter performance demonstrates our continued strength and resilience across all three of our businesses, said CEO Joaquin Duato.
Tuesday, October 18, 2022 at 10:34 am